| 于胜波,赵庆彦,崔红营,秦牧,刘韬,孔彬,黄鹤,黄从新.慢性收缩性心力衰竭患者药物治疗情况调查及相关因素分析[J].Chinese journal of Epidemiology,2012,33(2):229-233 |
| 慢性收缩性心力衰竭患者药物治疗情况调查及相关因素分析 |
| Investigation on the prevalence and related factors of medicinal therapy in patients with chronic systolic heart failure |
| Received:August 05, 2011 |
| DOI： |
| KeyWord: 心力衰竭 慢性收缩性 药物治疗 年龄 性别 |
| English Key Word: Chronic systolic heart failure Medicine therapy Age Gender |
| FundProject:国家自然科学基金(81070144) |
| Author Name | Affiliation | E-mail | | YU Sheng-bo | Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China | | | ZHAO Qing-yan | Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China | | | CUI Hong-ying | Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China | | | QIN Mu | Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China | | | LIU Tao | Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China | | | KONG Bin | Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China | | | HUANG He | Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China | | | HUANG Cong-xin | Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China | huangcongxin@yahoo.com.cn |
|
| Hits: 3536 |
| Download times: 1391 |
| Abstract: |
| 目的 分析湖北省慢性收缩性心力衰竭(心衰)患者药物治疗分布及其影响因素。方法 回顾性调查和分析2000—2010年湖北省8市12家三级甲等医院心衰住院患者资料, 根据年龄、性别和随访结果分组, 分析不同组间药物治疗种类和药费的分布差异。对药物治疗年费用进行log1()对数转换。结果 (1)共16681例心衰患者纳人研究, 随访期间有6453例死亡。死亡组药物治疗年费用低于存活组(3.19±0.65*?. 血管紧张素受体阻滞剂使用率随年龄增加而增加;而地高辛、利尿剂、p受体阻滞剂、血管紧张素转化酶抑制剂使用率随年龄增加呈倒“U”形分布。不同年龄组药物治疗存在性别差异。(3)随着患者年龄增加药物治疗费用有增加趋势(<30, 30~、40~、50~、60~和70~79岁组分别为2.96±0.70、3.09±0.62、3.15±0.58、3.30±0.59、3.25±0.58和3.35±0.60, 尸<0.01), 而年龄彡80岁组减低至50~岁组水平。男性患者药物治疗费的分布与全部患者水平相似, 而女性患者在<30、30~和40~岁组间无差异, 在其他年龄组的分布与全部患者水平相似。结论 湖北省心衰患者药物治疗有待改善, 药物治疗受年龄、性别影响, 其中女性患者药物治疗情况较男性差。 |
| English Abstract: |
| Objective To investigate the prevalence and related factors of medicinal therapy in patients with chronic systolic heart failure(CSHF). Methods Data on in-hospital patients with CSHF were studied from 12 hospitals in Hubei province, in 2000 and 2010. Differences on gender and age were calculated and Multivariate Cox regression analysis was performed to determinate the independent risk factors of all-cause mortality. Results(1) 16 681 patients were enrolled in this study. Among which, 6453 died during the 5.82 土 1.63 years of follow-up. The annual medical expenditure was larger in the survival group than in the dead ones(3.19 土 0.65 vs. 3.32 土 0.57, 0.01).(2) The prevalence of Angiotensin II receptor blocker increased along with age which accounted as 7.73%, 7.35%, 12.26%, 14.29%, 17.19%, 19.87% and 20.49%, respectively, in the <30, 30-39, 40-49, 50-59, 60-69, 70-79 and 多 80-year groups. The distribution of digitalis, diuretics, P-receptor blocker, Angiorensin- converting enzyke inhibitors showed inversed U shape.(3) The annual medical expenditure increased as patients got older, with age groups <30, 30-39, 40-49, 50-59, 60-69 and 70-79 years old as 2.96 士 0.70, 3.09 土 0.62, 3.15 土 0.58, 3.30 士 0.59 and 3.25 土 0.58, respectively(P<0.01). It reduced to the same level as in the 50-59 year-old group. The distribution of annual medical expenditure showed similar pattern in males. However, the trends were only found in patients at 50-59, 60-69, 70-79 and ^80 years-old groups in female. Conclusion More attention should be paid to medicinal therapy in patients with CSHF. Medicinal therapy shifted with age and gender, of which females had more adverse trend than in males. |
|
View Fulltext
Html FullText
View/Add Comment Download reader |
| Close |
|
|
|